NEUROCRINE BIOSCIENCES, INC. (NBIX) Revenue 2016–2025
NEUROCRINE BIOSCIENCES, INC. (NBIX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$2.9BFY2025 · since FY2016: $15.0M → $2.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.9B | +21.4% |
| FY2024 | $2.4B | +24.8% |
| FY2023 | $1.9B | +26.8% |
| FY2022 | $1.5B | +31.3% |
| FY2021 | $1.1B | +8.4% |
| FY2020 | $1.0B | +32.7% |
| FY2019 | $788.1M | +74.7% |
| FY2018 | $451.2M | +179.2% |
| FY2017 | $161.6M | +977.5% |
| FY2016 | $15.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice